TAILIEUCHUNG - báo cáo hóa học:" Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study"

Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học đề tài : Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study | Alves et al. Journal of Translational Medicine 2011 9 23 http content 9 1 23 TRANSLATIONAL MEDICINE RESEARCH Open Access Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock a prospective study Brunna E Alves 1 Silmara AL Montalvao1 Francisco JP Aranha1 Irene Lorand-Metze2 Carmino A De Souza2 Joyce M Annichino-Bizzacchi2 Erich V De Paula1 Abstract Background Septic shock is the most feared complication of chemotherapy-induced febrile neutropenia. So far there are no robust biomarkers that can stratify patients to the risk of sepsis complications. The VEGF-A axis is involved in the control of microvascular permeability and has been involved in the pathogenesis of conditions associated with endothelial barrier disruption such as sepsis. sFlt-1 is a soluble variant of the VEGF-A receptor VEGFR-1 that acts as a decoy receptor down-regulating the effects of VEGF-A. In animal models of sepsis sFlt-1 was capable to block the barrier-breaking negative effects of VEGF-A and to significantly decrease mortality. In non-neutropenic patients sFlt-1 has been shown to be a promising biomarker for sepsis severity. Methods We prospectively evaluated concentrations of sFlt-1 and VEGF-A at different time-points during febrile neutropenia and evaluated the association of these levels with sepsis severity and septic shock development. Results Neutropenic patients that evolved with septic shock n 10 presented higher levels of sFlt-1 and VEGF-A measured 48 hours after fever onset than patients with non-complicated sepsis n 31 and levels of these biomarkers correlated with sepsis severity scores. Estimation of the diagnostic accuracy of sFlt-1 levels for the discrimination of patients that evolved to septic shock yielded promising results in our study population. Discussion Our data suggest that sFlt-1 and VEGF-A could be useful biomarkers for sepsis severity in patients with febrile neutropenia. In addition the .

TÀI LIỆU LIÊN QUAN
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.